Preservation of Ovarian Cortex Tissue in Girls With Turner Syndrome

Status Active, not recruiting

Clinical Trial Summary

Rationale: Infertility due is a major concern for girls with Turner syndrome (TS) and their parents. Physicians are often asked about possible options to preserve their fertility. However, despite some experimental case reports, clear evidence for fertility preservation in these girls is lacking and many questions remain. Without evidence on the effectiveness of fertility preservation it cannot routinely be offered to girls with TS. Objective: To investigate the occurrence of live birth in women with TS after ovarian tissue cryopreservation in childhood followed by auto transplantation in adulthood. Study design: A national multicentre exploratory intervention study Study population: Girls diagnosed with Turner Syndrome, aged 2-18 years. Intervention: Ovarian tissue cryopreservation in childhood followed by auto transplantation in adulthood. In order to obtain the ovarian tissue for cryopreservation, all girls must undergo a laparoscopy under general anaesthesia which will be performed in academic/university clinics with paediatric surgery. During the laparoscopic intervention, a unilateral oophorectomy will be performed, thereby leaving the other ovary intact for hormone production, ovulation, spontaneous pregnancies and as an auto transplantation site for cryopreserved-thawed ovarian cortical tissue later on. Furthermore, a small sample of the ovarian cortex will be used to assess the oocyte quality and genetics (e.g. the presence of germ line mosaicism). Oocytes will be karyotyped by using Fluorescence in situ hybridization (FISH). Karyotypic and hormonal data will be collected once at the yearly clinical visit at the paediatric-endocrinologist. Therefore, a buccal swab and one extra blood sample will be taken and evaluated during the routine laboratory evaluation. In the future, auto transplantation of frozen-thawed ovarian cortex strips will be performed.

Clinical Trial Description

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The primary objective remains to preserve the fertility of the respective (minor) patient, facing a very high risk of premature ovarian insufficiency (POI) of 95-98%. Disadvantages of participating in this study are the potential risk of complications related to the laparoscopic unilateral oophorectomy and/or the unknown effect on future fertility of these girls. Moreover, the procedure might raise false hope in patients (and/or parents) about the chance of getting pregnant after auto transplantation of cryopreserved-thawed ovarian tissue in the future. However, we attempt to overcome this by extensive and objective information provision by both written materials and face to face counselling. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03381300
Study type	Interventional
Source	Radboud University Medical Center
Contact
Status	Active, not recruiting
Phase	N/A
Start date	January 1, 2018
Completion date	November 1, 2071

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01734486` - Growth Response in Girls With Turner Syndrome	Phase 4
Completed	`NCT01678261` - X-chromosome Inactivation, Epigenetics and the Transcriptome	N/A
Completed	`NCT01419249` - First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study	Phase 4
Completed	`NCT01518036` - Use of Somatropin in Turner Syndrome	Phase 3
Recruiting	`NCT04948658` - Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy
Completed	`NCT01563926` - Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency	Phase 3
Completed	`NCT02787486` - Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Completed	`NCT00877942` - Sex Differences in Early Brain Development; Brain Development in Turner Syndrome	N/A
Completed	`NCT00825617` - Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy	N/A
Recruiting	`NCT04463316` - GROWing Up With Rare GENEtic Syndromes
Enrolling by invitation	`NCT03836300` - Parent and Infant Inter(X)Action Intervention (PIXI)	N/A
Completed	`NCT01245374` - Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents	Phase 4
Completed	`NCT01322165` - National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions	N/A
Terminated	`NCT00419107` - Beta Cell Function in Women With Turner Syndrome	N/A
Active, not recruiting	`NCT00625001` - Long Term Follow-up of Bone Mineral Density in Hormone Treated Turner Syndrome	N/A
Completed	`NCT00029159` - The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome	Phase 3
Completed	`NCT01518062` - Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome	Phase 4
Completed	`NCT00471731` - Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure	N/A
Completed	`NCT00256126` - Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®	Phase 4
Completed	`NCT03181230` - Health, Fitness, and Quality of Life in Adolescent Girls With Turner Syndrome